AMGEN INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $7.7b $2.0b $8.4b $7.8b $7.3b $5.9b $6.6b $6.7b $4.1b $7.7b
Amortization of Intangible Assets $1.5b $1.3b $1.3b $1.4b $2.8b $2.6b $2.6b $3.2b $4.8b $4.3b
Depreciation $619.0m $604.0m $630.0m $635.0m $640.0m $644.0m $661.0m $685.0m $694.0m $763.0m
Depreciation, Depletion and Amortization $2.1b $2.0b $1.9b $2.2b $3.6b $3.4b $3.4b $4.1b $5.6b $5.2b
Depreciation, amortization and other $2.1b $2.0b $1.9b $2.2b $3.6b $3.4b $3.4b $4.1b $5.6b $5.2b
Deferred Income Tax Expense (Benefit) $216.0m ($1.3b) ($363.0m) ($304.0m) ($363.0m) ($434.0m) ($1.3b) ($1.2b) ($1.2b) ($700.0m)
Deferred income taxes $183.0m ($1.3b) ($363.0m) ($289.0m) ($287.0m) ($453.0m) ($1.2b) ($1.3b) ($1.2b) ($721.0m)
Impairment of Intangible Assets (Excluding Goodwill) $851.0m $159.0m $1.2b
Impairment of Intangible Assets, Finite-lived $851.0m $159.0m $1.2b
Impairment of intangible assets $851.0m $159.0m $1.2b
Payment, Tax Withholding, Share-based Payment Arrangement $260.0m $191.0m $126.0m $137.0m
Share-based Payment Arrangement, Expense $473.0m $530.0m $494.0m
Share-based Payment Arrangement, Noncash Expense $311.0m $329.0m $311.0m $308.0m $330.0m $341.0m $401.0m $431.0m $530.0m $494.0m
Gain (Loss) on Extinguishment of Debt $225.0m $215.0m $264.0m
Income (Loss) from Equity Method Investments ($891.0m) ($11.0m) $10.0m
Income Tax Expense (Benefit) $1.4b $7.6b $1.2b $1.3b $869.0m $808.0m $794.0m $1.1b $519.0m $1.3b
Changes in operating assets and liabilities:
Additional Financial Items
(Gains) losses on equity securities $0 $127.0m ($1.6b) $159.0m ($2.1b)
Accounts payable ($44.0m) $424.0m ($143.0m) $164.0m $45.0m ($69.0m) $154.0m ($402.0m) $312.0m $428.0m
Accrued income taxes, net ($301.0m) $523.0m ($361.0m) ($585.0m) ($249.0m) ($854.0m) ($647.0m) ($1.0b) ($1.0b) ($2.1b)
Accrued liabilities $97.0m $953.0m $92.0m $499.0m
Accrued sales incentives and allowance $404.0m $846.0m $935.0m $1.2b $2.1b
Cash paid for acquisitions, net of cash acquired $0 ($19.0m) $195.0m ($13.6b) $0 ($2.5b) ($3.8b) ($27.0b) $0 ($53.0m)
Equity Securities, FV-NI, Unrealized Gain (Loss) $174.0m $161.0m ($165.0m) $98.0m ($21.0m) $109.0m
Extinguishment of debt $0 $0 ($297.0m) ($647.0m) ($659.0m) ($683.0m)
Goodwill $14.8b $14.8b $14.7b $14.7b $14.7b $14.9b $15.5b $18.6b $18.6b $18.7b
Increase (Decrease) in Accounts Payable ($44.0m) $424.0m ($143.0m) $164.0m $45.0m ($69.0m) $154.0m ($402.0m) $312.0m $428.0m
Increase (Decrease) in Accounts Receivable $214.0m $58.0m $378.0m $504.0m $427.0m $429.0m $746.0m $1.0b ($441.0m) $2.7b
Increase (Decrease) in Inventories $80.0m ($133.0m) $3.0m $66.0m $215.0m $165.0m $742.0m ($491.0m) ($2.5b) ($886.0m)
Inventories ($80.0m) $133.0m ($3.0m) ($66.0m) ($215.0m) ($165.0m) ($742.0m) $491.0m $2.5b $886.0m
Investment Income, Interest $1.2b $510.0m $408.0m
Long-term tax liabilities $445.0m $6.7b $258.0m ($146.0m) ($482.0m) $204.0m $229.0m $371.0m ($492.0m) $311.0m
Nonoperating Income (Expense) $629.0m $928.0m $674.0m $753.0m $256.0m $259.0m ($814.0m) $2.8b $506.0m $2.7b
Other ($24.0m) $51.0m $58.0m $95.0m ($90.0m) ($78.0m) ($103.0m) ($72.0m) ($124.0m) ($52.0m)
Other assets ($128.0m) ($24.0m) $35.0m $10.0m $129.0m ($237.0m) $258.0m ($564.0m) ($652.0m) ($1.3b)
Other items, net $32.0m $334.0m $386.0m $186.0m ($195.0m) ($229.0m) ($176.0m) $563.0m ($8.0m) $149.0m
Other liabilities $768.0m $231.0m $1.2b $396.0m $983.0m $356.0m $761.0m $731.0m ($51.0m) ($156.0m)
Proceeds from maturities of marketable securities $2.5b $6.2b $5.4b $20.5b $4.4b $8.8b $1.1b $550.0m $0 $0
Proceeds from sales of marketable securities $18.0b $24.2b $28.4b $8.8b $2.6b $4.4b $98.0m $1.1b $0 $0
Restructuring Costs $12.0m
Revenue from Contract with Customer, Including Assessed Tax $23.4b $25.4b $26.0b $26.3b
Stock-based compensation expense $311.0m $329.0m $311.0m $308.0m $330.0m $341.0m $401.0m $431.0m $530.0m $494.0m
Trade receivables, net ($214.0m) ($58.0m) ($378.0m) ($504.0m) ($427.0m) ($429.0m) ($746.0m) ($1.0b) $441.0m ($2.7b)
Unrealized Gain (Loss) on Investments $1.6b ($159.0m) $2.1b
Net Cash Provided by (Used in) Operating Activities $10.4b $11.2b $11.3b $9.2b $10.5b $9.3b $9.7b $8.5b $11.5b $10.0b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $738.0m $664.0m $738.0m $618.0m $608.0m $880.0m $936.0m $1.1b $1.1b $1.9b
Payments to Acquire Businesses, Net of Cash Acquired $0 $19.0m ($195.0m) $13.6b $0 $2.5b $3.8b $27.0b $0 $53.0m
Payments for (Proceeds from) Other Investing Activities $222.0m $159.0m $145.0m $52.0m $75.0m $35.0m $12.0m ($225.0m) ($50.0m) $32.0m
Net Cash Provided by (Used in) Investing Activities ($8.7b) ($4.0b) $14.3b $5.7b ($5.4b) $733.0m ($6.0b) ($26.2b) ($1.0b) ($1.9b)
Cash flows from financing activities:
Net proceeds from issuance of debt $7.3b $4.5b $0 $0 $8.9b $4.9b $6.9b $27.8b $0 $0
Proceeds from Issuance of Long-term Debt $7.3b $4.5b $0 $0 $8.9b $4.9b $6.9b $27.8b $0 $0
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $2.5b $6.2b $5.4b $20.5b $4.4b $8.8b $1.1b $550.0m $0 $0
Repayment of debt ($3.7b) ($4.4b) ($1.1b) ($4.5b) ($6.5b) ($4.2b) $0 ($1.5b) ($3.6b) ($5.0b)
Repayments of Long-term Debt $3.7b $4.4b $1.1b $4.5b $6.5b $4.2b $0 $1.5b $3.6b $5.0b
Payments for Repurchase of Common Stock $3.0b $3.2b $17.8b $7.7b $3.5b $5.0b $6.4b $0 $200.0m $0
Payments of Ordinary Dividends, Common Stock $3.0b $3.4b $3.5b $3.5b $3.8b $4.0b $4.2b $4.6b $4.8b $5.1b
Repurchases of common stock ($3.0b) ($3.2b) ($17.8b) ($7.7b) ($3.5b) ($5.0b) ($6.4b) $0 ($200.0m) $0
Dividends Payable, Current $849.0m $953.0m $914.0m $946.0m $1.0b $1.1b $1.1b $1.2b $1.3b $1.4b
Dividends paid ($3k) ($3k) ($4k) ($4k) ($4k) ($4k) ($4k) ($5k) ($5k) ($5k)
Proceeds from (Payments for) Other Financing Activities ($24.0m) $51.0m $58.0m $95.0m ($90.0m) ($78.0m) ($103.0m) ($72.0m) ($124.0m) ($52.0m)
Net cash (used in) provided by financing activities ($2.6b) ($6.6b) ($22.5b) ($15.8b) ($4.9b) ($8.3b) ($4.0b) $21.0b ($9.4b) ($10.9b)
Net Cash Provided by (Used in) Financing Activities ($2.6b) ($6.6b) ($22.5b) ($15.8b) ($4.9b) ($8.3b) ($4.0b) $21.0b ($9.4b) ($10.9b)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($903.0m) $559.0m $3.1b ($908.0m) $229.0m $1.7b ($360.0m) $3.3b $1.0b ($2.8b)
(Decrease) increase in cash and cash equivalents ($903.0m) $559.0m $3.1b ($908.0m) $229.0m $1.7b ($360.0m) $3.3b $1.0b ($2.8b)
Cash and cash equivalents at beginning of year $4.1b $3.2b $3.8b $6.0b $6.3b $8.0b $7.6b $10.9b $12.0b $9.1b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.0b $6.3b $8.0b $7.6b $10.9b $12.0b $9.1b
Supplemental disclosure of cash flow information:
Income Taxes Paid, Net $4.3b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.